recombinant FVIIa concentrate

recombinant FVIIa concentrate, a concentrate of activated factor VII developed to treat bleeding in hemophilia patients with inhibitors. Activated factor VII acts directly on factor X and bypasses VIII or IX activity in the coagulation process.